![Kendall Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kendall Arthur Smith has been an Independent Non-Executive Director at ImmuneOnco Biopharmaceuticals (Shanghai), Inc. since 2022.
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. | Direktor/Vorstandsmitglied | 14.06.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 1 |
|---|---|
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd.
 ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
